Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2023
|
Johna Norton EVP, Global Quality |
SELL
Open market or private sale
|
Direct |
1,647
-5.19%
|
$737,856
$448.0 P/Share
|
|
Jun 14
2023
|
Johna Norton EVP, Global Quality |
SELL
Open market or private sale
|
Direct |
1,647
-4.93%
|
$731,268
$444.29 P/Share
|
|
Jun 01
2023
|
Diogo Rau EVP & CIDO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,848
-26.63%
|
$1,221,792
$429.46 P/Share
|
|
Jun 01
2023
|
Diogo Rau EVP & CIDO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+37.07%
|
-
|
|
Jun 01
2023
|
Patrik Jonsson EVP&Pres, CardMetHlth, LLY USA |
SELL
Open market or private sale
|
Direct |
6,000
-13.97%
|
$2,574,000
$429.46 P/Share
|
|
May 19
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
194,354
-0.03%
|
$86,293,176
$444.91 P/Share
|
|
May 15
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.66%
|
$4,774
$434.51 P/Share
|
|
May 15
2023
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
600
-9.12%
|
$261,000
$435.29 P/Share
|
|
May 15
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+1.04%
|
$9,548
$434.51 P/Share
|
|
May 15
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+0.22%
|
$14,322
$434.51 P/Share
|
|
May 15
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
26
+0.05%
|
$11,284
$434.51 P/Share
|
|
May 15
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.03%
|
$9,982
$434.51 P/Share
|
|
May 15
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+2.36%
|
$9,982
$434.51 P/Share
|
|
May 12
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
20,646
-0.01%
|
$9,146,178
$443.29 P/Share
|
|
May 03
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
178,302
-0.01%
|
$75,778,350
$425.09 P/Share
|
|
May 02
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
41,698
-0.01%
|
$17,054,482
$409.66 P/Share
|
|
Apr 28
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
225,000
-0.02%
|
$89,775,000
$399.57 P/Share
|
|
Apr 17
2023
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.01%
|
$1,860
$372.35 P/Share
|
|
Apr 17
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
26
+1.24%
|
$9,672
$372.35 P/Share
|
|
Apr 17
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
39
+0.26%
|
$14,508
$372.35 P/Share
|
|
Apr 17
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.78%
|
$4,836
$372.35 P/Share
|
|
Apr 17
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
30
+0.06%
|
$11,160
$372.35 P/Share
|
|
Apr 17
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+0.04%
|
$10,044
$372.35 P/Share
|
|
Apr 17
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+2.82%
|
$10,044
$372.35 P/Share
|
|
Apr 06
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
130,297
-0.02%
|
$47,818,999
$367.21 P/Share
|
|
Apr 05
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
69,703
-0.03%
|
$25,302,189
$363.72 P/Share
|
|
Apr 03
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.07%
|
$73,500,000
$350.79 P/Share
|
|
Mar 31
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.07%
|
$70,110,000
$342.71 P/Share
|
|
Mar 24
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
200,000
-0.1%
|
$67,200,000
$336.18 P/Share
|
|
Mar 20
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
43
+0.29%
|
$14,319
$333.6 P/Share
|
|
Mar 20
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.91%
|
$4,995
$333.6 P/Share
|
|
Mar 20
2023
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.01%
|
$1,998
$333.6 P/Share
|
|
Mar 20
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
30
+4.38%
|
$9,990
$333.6 P/Share
|
|
Mar 20
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
29
+1.4%
|
$9,657
$333.6 P/Share
|
|
Mar 20
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
34
+0.06%
|
$11,322
$333.6 P/Share
|
|
Mar 20
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
30
+0.04%
|
$9,990
$333.6 P/Share
|
|
Mar 10
2023
|
Alonzo Weems EVP, ERM & CECO |
SELL
Open market or private sale
|
Direct |
1,000
-10.09%
|
$318,000
$318.85 P/Share
|
|
Mar 01
2023
|
Alonzo Weems EVP, ERM & CECO |
SELL
Payment of exercise price or tax liability
|
Direct |
793
-7.41%
|
$246,623
$311.22 P/Share
|
|
Mar 01
2023
|
Alonzo Weems EVP, ERM & CECO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,779
+14.25%
|
-
|
|
Mar 01
2023
|
Eric Dozier EVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
714
-9.49%
|
$222,054
$311.22 P/Share
|
|
Mar 01
2023
|
Eric Dozier EVP, Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,602
+17.56%
|
-
|
|
Mar 01
2023
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
843
-3.04%
|
$262,173
$311.22 P/Share
|
|
Mar 01
2023
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,890
+6.39%
|
-
|
|
Feb 27
2023
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
600
-8.36%
|
$193,200
$322.47 P/Share
|
|
Feb 21
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
44
+0.3%
|
$14,388
$327.51 P/Share
|
|
Feb 21
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
30
+1.47%
|
$9,810
$327.51 P/Share
|
|
Feb 21
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.92%
|
$4,905
$327.51 P/Share
|
|
Feb 21
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
30
+4.59%
|
$9,810
$327.51 P/Share
|
|
Feb 21
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
35
+0.07%
|
$11,445
$327.51 P/Share
|
|
Feb 21
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
30
+0.04%
|
$9,810
$327.51 P/Share
|